EBD Group is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Jeff Bockman is EVP, Head of Oncology at Defined Health. Jeff has extensive commercial and strategic perspective on the pharmaceutical and biotech industries. He has directed hundreds of opportunity, valuation and strategic assessments during his tenure at DH. He often speaks at conferences on scientific/clinical and commercial/strategic issues in cancer, especially in Immuno-Oncology. He was a Senior Research Scientist developing oligonucleotide therapeutics for viral diseases and cancer at Innovir Laboratories in collaboration with Sidney Altman at Yale. Prior to this, Jeff was Assistant Research Professor at The George Washington University School of Medicine. He received a BA from University of California at San Diego, a PhD from the University of California at Berkeley on prions in collaboration with Stand Prusiner at UCSF, and an MA in Creative Writing from New York University. Jeff is a member of LES, AACR, ASCO, ASH, SITC, ASGCT. and NYAS.